Sun Fanglin, a leading cancer researcher at Tongji University in Shanghai, died on July 10 at the age of 58, leaving behind a body of work that sits at the fragile boundary between biological understanding and human survival. His investigations into cellular aging, gene regulation, and the mechanisms of tumor drug resistance gave science not merely new data, but a conceptual architecture upon which future therapies may yet be built. He was 58 — an age that reminds us how often the work outlives the worker, and how much depends on those who choose to pursue the hardest questions.
Leading Chinese cancer researcher Sun Fanglin dies at 58
Sun Fanglin died at age 58 from an undisclosed illness, representing a loss to the scientific community and ongoing cancer research initiatives.